Control of exocrine secretion in the guinea-pig pancreas by histamine H3 receptors.
The aim of this study was to investigate the possible involvement of the histamine H3 receptor in control of exocrine pancreatic secretion from the guinea-pig. In in vitro experiments, the H3 receptor agonist (R)-alpha-methylhistamine (0.01-10 microM) elicited a concentration-dependent decrease in the release of alpha-amylase. (R)-alpha-Methylhistamine concentrations above 10 microM evoked a concentration-dependent increase in alpha-amylase secretion. Application of mepyramine (1 microM) partially blocked this increase. The H3 receptor antagonist thioperanide (1 microM) blocked the effects of (R)-alpha-methylhistamine below 10 microM. Histamine and (R)-alpha-methylhistamine attenuated both protein release elicited during electrical-field stimulation and the release of tritiated choline, and these effects were reversed by thioperamide. In an in vivo study, (R)-alpha-methylhistamine increased juice secretion and total protein content of the juice by 40%. Histamine H1 and H2 receptor antagonists blocked this increase and uncovered an attenuation of the secretory parameters (juice flow 28%, total protein content 44%). This attenuation was blocked by thioperamide. These observations suggest that stimulation of the histamine H3 receptor in the pancreas results in a decreased fluid and enzyme release by inhibition of acetylcholine release from intrinsic pancreatic nerves.
Department of Applied Biology, University of Central Lancashire, Preston, England, UK.
L J
LJ
Jennings
G M
GM
Salido
J A
JA
Pariente
J S
JS
Davison
J
J
Singh
K A
KA
Sharkey
D000818:Animals; D002794:Choline / Q000378:metabolism; D004558:Electric Stimulation; D005260:Female; D006168:Guinea Pigs; D017442:Histamine Agonists / Q000494:pharmacology; D006633:Histamine Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008761:Methylhistamines / Q000494:pharmacology; D010179:Pancreas / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology; D011738:Pyrilamine / Q000008:administration & dosage / Q000494:pharmacology; D018100:Receptors, Histamine H3 / Q000502:physiology*; D014316:Tritium; D000516:alpha-Amylases / Q000378:metabolism
D017442:Histamine Agonists; D006633:Histamine Antagonists; D008761:Methylhistamines; D010880:Piperidines; D018100:Receptors, Histamine H3; D014316:Tritium; C069357:alpha-methylhistamine; D000516:alpha-Amylases; D011738:Pyrilamine; C052075:thioperamide; D002794:Choline